Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: presentation (144), act (353), routine (244), concert (7), show (694), feat (5)

Binimetinib-Encorafenib

Description: Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectable or metastatic BRA
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf

Lenvatinib(60kg or greater)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description: Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

Cisplatin-Gemcitabine Version 1.2

Description: Chemotherapy Protocol BILIARY TRACT CANCER CISPLATIN-GEMCITABINE Regimen Biliary Tract Cancer – Cisplatin-Gemcitabine Indication First line therapy of locally advanced / m
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Cisplatin-Gemcitabine-Version-12.pdf

Nivolumab_240mg

Description: Chemotherapy Protocol HEAD AND NECK CANCER Nivolumab (240mg-14 days) Regimen • Head and Neck – Nivolumab (240mg-14 days) Indication • The treatment of recurrent or met
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Nivolumab-240mg.pdf

Nivolumab

Description: Chemotherapy Protocol HEAD AND NECK CANCER Nivolumab Regimen • Head and Neck – Nivolumab Indication • The treatment of recurrent or metastatic squamous cell carcinoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Nivolumab.pdf

Cetuximab-Radiotherapy (7 day)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CETUXIMAB RT (7 day) Regimen • Head and Neck Cancer – Cetuximab RT (7 day) Indication • Cetuxima
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cetuximab-Radiotherapy7day.pdf

Capecitabine-Epirubicin-Oxaliplatin (EOX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, EPIRUBICIN and OXALIPLATIN (EOX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Epirubicin-Oxaliplatin (EOX) Indica
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Epirubicin-Oxaliplatin.pdf

Capecitabine-Cisplatin-Epirubicin (ECX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, CISPLATIN and EPIRUBICIN (ECX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Cisplatin-Epirubicin (ECX) Indicatio
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Epirubicin.pdf

Ipilimumab-Nivolumab Ver1

Description: Chemotherapy Protocol MESOTHELIOMA IPILIMUMAB-NIVOLUMAB Regimen • Mesothelioma – Ipilimumab-Nivolumab Indication • Nivolumab in combination with ipilimumab is ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/Ipilimumab-Nivolumab-Ver1.pdf

501 to 510 of 596

Previous … 49 50 51 52 53 … Next